Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Cash And Cash Equivalents : £1.13 Mil (As of Oct. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Cash And Cash Equivalents?

Oxford Cannabinoid Technologies Holdings's quarterly cash and cash equivalents declined from Oct. 2022 (£4.93 Mil) to Apr. 2023 (£2.30 Mil) but then stayed the same from Apr. 2023 (£2.30 Mil) to Oct. 2023 (£1.13 Mil).

Oxford Cannabinoid Technologies Holdings's annual cash and cash equivalents increased from May. 2020 (£0.31 Mil) to May. 2021 (£14.63 Mil) but then declined from May. 2021 (£14.63 Mil) to Apr. 2023 (£2.30 Mil).

Oxford Cannabinoid Technologies Holdings Cash And Cash Equivalents Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Cash And Cash Equivalents Chart

Oxford Cannabinoid Technologies Holdings Annual Data

Trend

May18

May19

May20

May21

Apr23

Cash And Cash Equivalents

0.01

1.65

0.31

14.63

2.30

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
	May19	Nov19	May20	Nov20	May21	Nov21	Oct22	Apr23	Oct23
Cash And Cash Equivalents	Get a 7-Day Free Trial				14.63	12.02	4.93	2.30	1.13

Oxford Cannabinoid Technologies Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Oxford Cannabinoid Technologies Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

0CB:Germany

Address

267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT

Website

https://www.oxcantech.com

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (LSE:OCTP) Headlines

No Headlines